NCT00395304View on ClinicalTrials.gov

Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Asthma
Interventions
DRUG

fluticasone propionate + montelukast

Dry-powder inhaler fluticasone 100 mcg bid (Flovent Diskus®, GlaxoSmithKline) plus Montelukast 5 or 10 mg qd (Singulair®, Merck)

DRUG

fluticasone propionate

Dry-powder inhaler fluticasone 250 mcg bid (Flovent Diskus®, GlaxoSmithKline)

DRUG

fluticasone propionate + salmeterol

Dry-powder inhaler fluticasone + salmeterol combination 100 mcg/50 mcg bid (Advair Diskus®, GlaxoSmithKline)

Trial Locations (5)

53792

University of Wisconsin - Madison, Madison

63110

Washington University School of Medicine, St Louis

80206

National Jewish Medical and Research Center, Denver

85724

University of Arizona College of Medicine, Tucson

92111

Kaiser Permanente Medical Center, San Diego

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT00395304 - Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) | Biotech Hunter | Biotech Hunter